Meaghan Bartlett

Publication Activity (10 Years)

Years Active: 2021-2024
Publications (10 Years): 4

Top Topics

Systematic Review

Ejection Fraction

Multiple Myeloma

Top Venues

Current medical research and opinion

Future oncology (London, England)

Journal of comparative effectiveness research

This page only lists publications with an associated author ORCID identifier.

Publications

Imtiaz A Samjoo, Alexandra Hall, Connie Chen, Nguyen Bao Ngoc, Meaghan Bartlett, Mary Lou Smith, Nadia Harbeck, Joseph Christopher Cappelleri, Meghan Karuturi, Doris Makari, Lillian Shahied Arruda, Rickard Sandin, Kent A Hanson, Justin Doan
A systematic review of health-related quality of life outcomes in patients with advanced breast cancer treated with palbociclib. Journal of comparative effectiveness research (2024)
Luciano J Costa, Parameswaran Hari, Jesus G Berdeja, Valerio De Stefano, Francesca Gay, Becky Hooper, Meaghan Bartlett, Anja Haltner, Emily Rosta, Shaji K Kumar, Thomas Martin, Maria-Victoria Mateos-Manteca, Philippe Moreau, Saad Z Usmani, Yunsi Olyslager, Jordan M Schecter, Tito Roccia, Ashraf Garrett, Sam Lee, Tonia Nesheiwat, Lida Pacaud, Changwei Zhou, Imtiaz A Samjoo, Yi Lin, Joris Diels, Satish Valluri, Katja Weisel
Meta-analysis of ciltacabtagene autoleucel versus physician's choice therapy for the treatment of patients with relapsed or refractory multiple myeloma. Current medical research and opinion 38 (10) (2022)
Tom Martin, Saad Z Usmani, Jordan M Schecter, Tito Roccia, Carolyn C Jackson, William Deraedt, Tzu-Min Yeh, Arnob Banerjee, Lida Pacaud, Ashraf Garrett, Meaghan Bartlett, Anja Haltner, Suzy Van Sanden, Joris Diels, Satish Valluri, Imtiaz A Samjoo
Updated results from a matching-adjusted indirect comparison of efficacy outcomes for ciltacabtagene autoleucel in CARTITUDE-1 versus idecabtagene vicleucel in KarMMa for the treatment of patients with relapsed or refractory multiple myeloma. Current medical research and opinion (2022)
Nadia Harbeck, Meaghan Bartlett, Dean Spurden, Becky Hooper, Lin Zhan, Emily Rosta, Chris Cameron, Debanjali Mitra, Anna Zhou
CDK4/6 inhibitors in HR+/HER2- advanced/metastatic breast cancer: a systematic literature review of real-world evidence studies. Future oncology (London, England) 17 (16) (2021)